Summary by Futu AI
Kingsway Biotechnology will hold its Annual General Meeting on 17 May 2024 at Nanjing City, Jiangsu Province, China. The meeting will consider a number of ordinary resolutions, including the audit of the 2013 financial statements and the Board of Directors and Auditor's reports, the re-election of five directors, including Dr. Zhang Fang Leung, and the authorization of the Board to determine the remuneration of directors. In addition, the meeting will renew the appointment of EY Accounting Firm as auditor and authorize the Board to determine remuneration. Special items include the approval of the Directors' power to issue new shares or purchase company shares within a specified period, as well as to revise the Company's Stock Option Plan and Restricted Share Award Scheme. The meeting will also consider the adoption of the fourth revised and revised Articles of Association and Conditions. Shareholders will not be able to register shares from 13 to 17 May to determine their eligibility to attend the general meeting and vote.